title: Assessment of data pre-processing methods for LC-MS/MS-based metabolomics of uterine cervix cancer.
abstract: A metabolomics strategy based on rapid resolution liquid chromatography/tandem mass spectrometry (RRLC-MS/MS) and multivariate statistics has been implemented to identify potential biomarkers in uterine cervix cancer. Due to the importance of the data pre-processing method, three popular software packages have been compared. Then they have been used to acquire respective data matrices from the same LC-MS/MS data. Multivariate statistics was subsequently used to identify significantly changed biomarkers for uterine cervix cancer from the resulting data matrices. The reliabilities of the identified discriminated metabolites have been further validated on the basis of manually extracted data and ROC curves. Nine potential biomarkers have been identified as having a close relationship with uterine cervix cancer. Considering these in combination as a biomarker group, the AUC amounted to 0.997, with a sensitivity of 92.9% and a specificity of 95.6%. The prediction accuracy was 96.6%. Among these potential biomarkers, the amounts of four purine derivatives were greatly decreased, which might be related to a P2 receptor that might lead to a decrease in cell number through apoptosis. Moreover, only two of them were identified simultaneously by all of the pre-processing tools. The results have demonstrated that the data pre-processing method could seriously bias the metabolomics results. Therefore, application of two or more data pre-processing methods would reveal a more comprehensive set of potential biomarkers in non-targeted metabolomics, before a further validation with LC-MS/MS based targeted metabolomics in MRM mode could be conducted.
authors.affiliation: State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, PR China.
authors.forename: Yanhua
authors.initials: Y
authors.lastname: Chen
authors.forename: Jing
authors.initials: J
authors.lastname: Xu
authors.forename: Ruiping
authors.initials: R
authors.lastname: Zhang
authors.forename: Guoqing
authors.initials: G
authors.lastname: Shen
authors.forename: Yongmei
authors.initials: Y
authors.lastname: Song
authors.forename: Jianghao
authors.initials: J
authors.lastname: Sun
authors.forename: Jiuming
authors.initials: J
authors.lastname: He
authors.forename: Qimin
authors.initials: Q
authors.lastname: Zhan
authors.forename: Zeper
authors.initials: Z
authors.lastname: Abliz
mesh_terms: D014408:Biomarkers, Tumor / Q000378:metabolism*; D002584:Cervix Uteri / Q000378:metabolism* / Q000473:pathology*; D002853:Chromatography, Liquid / Q000379:methods; D005260:Female; D006801:Humans; D055432:Metabolomics / Q000379:methods*; D015999:Multivariate Analysis; D053719:Tandem Mass Spectrometry / Q000379:methods*; D002583:Uterine Cervical Neoplasms / Q000378:metabolism* / Q000473:pathology*
chemical_list: D014408:Biomarkers, Tumor